brl 42810 has been researched along with Hepatitis B Virus Infection in 61 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Lamivudine and famciclovir combination therapy has been used in patients with chronic HBeAg-positive hepatitis B to enhance the antiviral effect and reduce the risk of development of resistance." | 9.10 | Lamivudine and famciclovir combination therapy with or without addition of interferon-alpha-2b for HBeAg-positive chronic hepatitis B: a pilot study. ( Hollander, A; Lindh, G; Sangfelt, P; Uhnoo, I; Weiland, O, 2002) |
| "Preliminary results of short-term famciclovir and lamivudine therapy in patients with hepatitis B virus (HBV) infection after liver transplantation revealed promising results." | 7.71 | Comparison of famciclovir and lamivudine in the long-term treatment of hepatitis B infection after liver transplantation. ( Bechstein, WO; Hopf, U; Naumann, U; Neuhaus, P; Neuhaus, R; Rayes, N; Seehofer, D, 2001) |
| "Individuals coinfected with human immunodeficiency virus 1 (HIV-1) and hepatitis B virus (HBV) often receive treatment with an antiretroviral regimen including lamivudine." | 7.71 | Failure of combination therapy with lamivudine and famciclovir following lamivudine monotherapy for hepatitis B virus infection in patients coinfected with human immunodeficiency virus-1. ( Cane, P; Gazzard, B; Matthews, GV; Nelson, M; Pillay, D; Ratcliffe, D, 2001) |
| "Lamivudine is a nucleoside analogue with efficacy in the suppression of hepatitis B viral (HBV) replication." | 7.70 | Postliver transplant allograft reinfection with a lamivudine-resistant strain of hepatitis B virus: long-term follow-up. ( Bain, VG; Davis, JE; Erb, SR; Fischer, KP; Kneteman, NM; Ma, MM; Tyrrell, DL; Yoshida, EM, 1998) |
| "Famciclovir (FCV) and lamivudine (LAM) reduce viral replication in patients with recurrent hepatitis B virus (HBV) infection after orthotopic liver transplantation (OLT)." | 7.70 | Mutational pattern of hepatitis B virus on sequential therapy with famciclovir and lamivudine in patients with hepatitis B virus reinfection occurring under HBIg immunoglobulin after liver transplantation. ( Bock, T; Böker, KH; Bruns, I; Condreay, LD; Gauthier, J; Glowienka, M; Jäckel, E; Manns, MP; Oldhafer, K; Raab, HR; Tillmann, HL; Trautwein, C, 1999) |
| "We have documented HBV recurrence in a liver transplant recipient with the emergence of a multidrug resistant HBV which caused graft loss." | 5.30 | The sequential occurrence of viral mutations in a liver transplant recipient re-infected with hepatitis B: hepatitis B immune globulin escape, famciclovir non-response, followed by lamivudine resistance resulting in graft loss. ( Bartholomeusz, AI; de Man, RA; Locarnini, SA; Niesters, HG; Zondervan, PE, 1998) |
| "Lamivudine and famciclovir combination therapy has been used in patients with chronic HBeAg-positive hepatitis B to enhance the antiviral effect and reduce the risk of development of resistance." | 5.10 | Lamivudine and famciclovir combination therapy with or without addition of interferon-alpha-2b for HBeAg-positive chronic hepatitis B: a pilot study. ( Hollander, A; Lindh, G; Sangfelt, P; Uhnoo, I; Weiland, O, 2002) |
| " Lamivudine is safe and effective in liver transplant recipients with recurrent hepatitis B virus (HBV) infection caused by wild-type virus or failure of hepatitis B immunoglobulin therapy." | 3.71 | Treatment of recurrent hepatitis B infection in liver transplant recipients. ( Terrault, NA, 2002) |
| "Preliminary results of short-term famciclovir and lamivudine therapy in patients with hepatitis B virus (HBV) infection after liver transplantation revealed promising results." | 3.71 | Comparison of famciclovir and lamivudine in the long-term treatment of hepatitis B infection after liver transplantation. ( Bechstein, WO; Hopf, U; Naumann, U; Neuhaus, P; Neuhaus, R; Rayes, N; Seehofer, D, 2001) |
| "Individuals coinfected with human immunodeficiency virus 1 (HIV-1) and hepatitis B virus (HBV) often receive treatment with an antiretroviral regimen including lamivudine." | 3.71 | Failure of combination therapy with lamivudine and famciclovir following lamivudine monotherapy for hepatitis B virus infection in patients coinfected with human immunodeficiency virus-1. ( Cane, P; Gazzard, B; Matthews, GV; Nelson, M; Pillay, D; Ratcliffe, D, 2001) |
| "Lamivudine is a nucleoside analogue with efficacy in the suppression of hepatitis B viral (HBV) replication." | 3.70 | Postliver transplant allograft reinfection with a lamivudine-resistant strain of hepatitis B virus: long-term follow-up. ( Bain, VG; Davis, JE; Erb, SR; Fischer, KP; Kneteman, NM; Ma, MM; Tyrrell, DL; Yoshida, EM, 1998) |
| "Famciclovir (FCV) and lamivudine (LAM) reduce viral replication in patients with recurrent hepatitis B virus (HBV) infection after orthotopic liver transplantation (OLT)." | 3.70 | Mutational pattern of hepatitis B virus on sequential therapy with famciclovir and lamivudine in patients with hepatitis B virus reinfection occurring under HBIg immunoglobulin after liver transplantation. ( Bock, T; Böker, KH; Bruns, I; Condreay, LD; Gauthier, J; Glowienka, M; Jäckel, E; Manns, MP; Oldhafer, K; Raab, HR; Tillmann, HL; Trautwein, C, 1999) |
| "Hepatitis B virus (HBV) drug resistance to lamivudine is always accompanied by mutations in the viral polymerase gene at position 550, termed group 1 (M550V with L526M) or group 2 (M550I) mutations." | 3.70 | Selection of multiresistant hepatitis B virus during sequential nucleoside-analogue therapy. ( Cane, PA; Cook, P; Dowling, D; Elias, E; Mutimer, D; O'Donnell, K; Pillay, D; Ratcliffe, D; Shaw, J, 2000) |
| "In 12 patients with hematologic malignancies, we performed a prospective study to determine the effectiveness of nucleoside analogues in the pre-emptive therapy of chemotherapy-induced HBV reactivation." | 2.72 | A prospective study on chemotherapy-induced hepatitis B virus reactivation in chronic HBs Ag carriers with hematologic malignancies and pre-emptive therapy with nucleoside analogues. ( Acar, K; Aki, Z; Bozdayi, G; Haznedar, R; Sucak, GT; Yağci, M, 2006) |
| "Today, hepatitis B is a universally accepted indication for OLT." | 2.41 | Hepatitis B: progress in the last 15 years. ( Villamil, FG, 2002) |
| "Posttransplant treatment with hepatitis B immune globulin (HBIG) is now the standard of care, but patients appear to require lifelong treatment to prevent reinfection." | 2.41 | Posttransplantation: emerging and future therapies. ( Kruger, M; Lake, JR; Perrillo, RP; Sievers, T, 2000) |
| "Lamivudine resistance has been found to confer cross-resistance to some of these compounds and it is likely that resistance to newer antivirals may also develop during prolonged use." | 2.41 | Resistance of hepatitis B virus to antiviral drugs: current aspects and directions for future investigation. ( Delaney, WE; Locarnini, S; Shaw, T, 2001) |
| "Lamivudine has emerged as another effective first-line therapy for chronic hepatitis B as well as a beneficial treatment option for patients with decompensated hepatitis B cirrhosis." | 2.41 | Therapeutic advances in the management of hepatitis B and hepatitis C. ( Nguyen, MH; Wright, TL, 2001) |
| "Famciclovir is the well-absorbed oral form of penciclovir, an antiviral agent with potent activity against varicella-zoster virus (VZV) and herpes simplex virus (HSV-1) and 2 (HSV-2)." | 2.39 | Famciclovir: review of clinical efficacy and safety. ( Cirelli, R; Herne, K; Lee, P; McCrary, M; Tyring, SK, 1996) |
| " The treatment for recurrent hepatitis B after liver transplantation includes increased dosage of lamivudine, application of famciclovir, and other liver protection measures." | 1.31 | Prophylaxis and treatment of hepatitis B virus reinfection following liver transplantation. ( Huang, DS; Liang, TB; Wang, WL; Wu, J; Xu, X; Zheng, SS, 2002) |
| " The aims of this pilot study were to determine the effectiveness and safety of long-term administration of famciclovir in recurrent (n = 3) and de novo (n = 3) HBV infection after liver transplantation." | 1.31 | Famciclovir treatment in transplant recipients with HBV-related liver disease: disappointing results. ( Berenguer, J; Berenguer, M; Bustamante, M; Carrasco, D; Gobernado, M; Mir, J; Moya, A; Pastor, MA; Prieto, M; Rayón, M, 2001) |
| "In contrast only 18% developed HBV recurrence under perioperative lamivudine treatment." | 1.31 | Preoperative antiviral treatment and postoperative prophylaxis in HBV-DNA positive patients undergoing liver transplantation. ( Bechstein, WO; Berg, T; Müller, AR; Naumann, U; Neuhaus, P; Neuhaus, R; Rayes, N; Seehofer, D; Steinmüller, T; Tullius, SG, 2001) |
| "The association between polyarteritis nodosa and viral hepatitis B infection is well established and still remains a therapeutic challenge." | 1.30 | Treatment of hepatitis B-related polyarteritis nodosa with famciclovir and interferon alfa-2b. ( Böker, KH; Kruger, M; Manns, MP; Zeidler, H, 1997) |
| "Famciclovir is a useful agent in the treatment of hepatitis B in the liver transplant recipient." | 1.30 | Resolution of recurrent hepatitis B in two liver transplant recipients treated with famciclovir. ( Busuttil, RW; Han, SH; Hiserodt, D; Holt, C; Imagawa, D; Kinkhabwala, M; Martin, P; Murray, N; Rudich, S; Seu, P, 1998) |
| "We have documented HBV recurrence in a liver transplant recipient with the emergence of a multidrug resistant HBV which caused graft loss." | 1.30 | The sequential occurrence of viral mutations in a liver transplant recipient re-infected with hepatitis B: hepatitis B immune globulin escape, famciclovir non-response, followed by lamivudine resistance resulting in graft loss. ( Bartholomeusz, AI; de Man, RA; Locarnini, SA; Niesters, HG; Zondervan, PE, 1998) |
| "New concepts for the treatment of hepatitis B in immunocompromised patients are urgently needed." | 1.29 | Prostaglandin E plus famciclovir--a new concept for the treatment of severe hepatitis B after liver transplantation. ( Böker, KH; Krüger, M; Manns, MP; Pichlmayr, R; Ringe, B, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 27 (44.26) | 18.2507 |
| 2000's | 33 (54.10) | 29.6817 |
| 2010's | 1 (1.64) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wiegand, J | 1 |
| Wedemeyer, H | 1 |
| Finger, A | 1 |
| Heidrich, B | 1 |
| Rosenau, J | 1 |
| Michel, G | 1 |
| Bock, CT | 1 |
| Manns, MP | 5 |
| Tillmann, HL | 2 |
| Mubareka, S | 1 |
| Leung, V | 1 |
| Aoki, FY | 1 |
| Vinh, DC | 1 |
| Sangfelt, P | 1 |
| Uhnoo, I | 1 |
| Hollander, A | 1 |
| Lindh, G | 1 |
| Weiland, O | 1 |
| Fischer, L | 3 |
| Sterneck, M | 3 |
| Meier, D | 1 |
| Zöllner, B | 2 |
| Rogiers, X | 2 |
| Brown, TJ | 1 |
| McCrary, M | 2 |
| Tyring, SK | 2 |
| Villamil, FG | 1 |
| Terrault, NA | 2 |
| Zheng, SS | 1 |
| Wu, J | 1 |
| Liang, TB | 1 |
| Wang, WL | 1 |
| Huang, DS | 1 |
| Xu, X | 1 |
| Berenguer, M | 2 |
| Wright, TL | 3 |
| Yağci, M | 2 |
| Acar, K | 2 |
| Sucak, GT | 1 |
| Aki, Z | 1 |
| Bozdayi, G | 1 |
| Haznedar, R | 1 |
| Panos, GZ | 1 |
| Lampropoulos, KM | 1 |
| Angelousi, AG | 1 |
| Charatsis, GG | 1 |
| Falagas, ME | 1 |
| Goffin, E | 1 |
| Horsmans, Y | 1 |
| Pirson, Y | 1 |
| Cornu, C | 1 |
| Geubel, A | 1 |
| van Ypersele De Strihou, C | 1 |
| Schalm, SW | 2 |
| de Man, RA | 3 |
| Heijtink, RA | 2 |
| Niesters, HG | 3 |
| Böker, KH | 3 |
| Ringe, B | 1 |
| Krüger, M | 3 |
| Pichlmayr, R | 1 |
| Cirelli, R | 1 |
| Herne, K | 1 |
| Lee, P | 1 |
| Main, J | 1 |
| Brown, JL | 1 |
| Howells, C | 1 |
| Galassini, R | 1 |
| Crossey, M | 1 |
| Karayiannis, P | 1 |
| Georgiou, P | 1 |
| Atkinson, G | 1 |
| Thomas, HC | 1 |
| Haller, GW | 1 |
| Bechstein, WO | 5 |
| Neuhaus, R | 5 |
| Raakow, R | 1 |
| Berg, T | 4 |
| Hopf, U | 3 |
| Neuhaus, P | 6 |
| Zeidler, H | 1 |
| Singh, N | 1 |
| Gayowski, T | 1 |
| Wannstedt, CF | 1 |
| Wagener, MM | 1 |
| Marino, IR | 1 |
| Piqueras, B | 1 |
| Salcedo, M | 1 |
| Bañares, R | 1 |
| García-Durán, F | 1 |
| Baños, E | 1 |
| de Diego, A | 1 |
| Roldán, P | 1 |
| Cos, E | 1 |
| Clemente, G | 1 |
| Klein, M | 1 |
| Geoghegan, J | 1 |
| Schmidt, K | 1 |
| Böckler, D | 1 |
| Korn, K | 1 |
| Wittekind, C | 1 |
| Scheele, J | 1 |
| Perrillo, RP | 3 |
| Lau, GK | 3 |
| Liang, R | 2 |
| Wu, PC | 1 |
| Lee, CK | 2 |
| Lim, WL | 1 |
| Au, WY | 1 |
| Yoshida, EM | 1 |
| Ma, MM | 1 |
| Davis, JE | 1 |
| Fischer, KP | 1 |
| Kneteman, NM | 1 |
| Erb, SR | 1 |
| Tyrrell, DL | 1 |
| Bain, VG | 1 |
| Golling, M | 1 |
| Arnold, JC | 1 |
| Rudek, B | 1 |
| Theilmann, L | 1 |
| Herfarth, C | 1 |
| Otto, G | 1 |
| Bartholomeusz, A | 1 |
| Groenen, LC | 1 |
| Locarnini, SA | 3 |
| Mutimer, D | 3 |
| Han, SH | 1 |
| Kinkhabwala, M | 1 |
| Martin, P | 1 |
| Holt, C | 1 |
| Murray, N | 1 |
| Seu, P | 1 |
| Rudich, S | 1 |
| Hiserodt, D | 1 |
| Imagawa, D | 1 |
| Busuttil, RW | 1 |
| Bartholomeusz, AI | 1 |
| Zondervan, PE | 1 |
| Sata, M | 1 |
| Kumashiro, R | 1 |
| Günther, S | 1 |
| von Breunig, F | 1 |
| Santantonio, T | 1 |
| Jung, MC | 1 |
| Gaeta, GB | 1 |
| Will, H | 1 |
| Trautwein, C | 1 |
| Bock, T | 1 |
| Jäckel, E | 1 |
| Glowienka, M | 1 |
| Oldhafer, K | 1 |
| Bruns, I | 1 |
| Gauthier, J | 1 |
| Condreay, LD | 1 |
| Raab, HR | 1 |
| Pillay, D | 3 |
| Cane, PA | 2 |
| Shaw, T | 2 |
| Rayes, N | 4 |
| Seehofer, D | 4 |
| Müller, AR | 3 |
| Cook, P | 1 |
| Ratcliffe, D | 2 |
| O'Donnell, K | 1 |
| Dowling, D | 1 |
| Shaw, J | 1 |
| Elias, E | 1 |
| Sievers, T | 1 |
| Lake, JR | 1 |
| Myers, RP | 1 |
| Chaudhary, R | 1 |
| Fonseca, K | 1 |
| Lee, SS | 1 |
| Naumann, U | 2 |
| Prieto, M | 1 |
| Rayón, M | 1 |
| Bustamante, M | 1 |
| Carrasco, D | 1 |
| Moya, A | 1 |
| Pastor, MA | 1 |
| Gobernado, M | 1 |
| Mir, J | 1 |
| Berenguer, J | 1 |
| Suárez García, E | 1 |
| Romero Gómez, M | 1 |
| Grande Santamaría, L | 1 |
| Forns, X | 1 |
| Sánchez-Tapias, JM | 1 |
| Cahlin, C | 1 |
| Olausson, M | 1 |
| Friman, S | 1 |
| Atkinson, GF | 1 |
| Griffin, KE | 1 |
| Barnass, S | 1 |
| Vollmar, J | 1 |
| Yeang, Y | 1 |
| Young, CL | 1 |
| Delaney, WE | 1 |
| Locarnini, S | 2 |
| Lewin, SR | 1 |
| Ribeiro, RM | 1 |
| Walters, T | 1 |
| Bowden, S | 1 |
| Perelson, AS | 1 |
| Tullius, SG | 1 |
| Steinmüller, T | 1 |
| Matthews, GV | 1 |
| Cane, P | 1 |
| Gazzard, B | 1 |
| Nelson, M | 1 |
| Tang, S | 1 |
| Ho, SK | 1 |
| Moniri, K | 1 |
| Lai, KN | 1 |
| Chan, TM | 1 |
| Hou, J | 1 |
| Wang, Z | 1 |
| Sun, J | 1 |
| Yuan, G | 1 |
| Duan, Y | 1 |
| Wang, F | 1 |
| Liang, S | 1 |
| Zhu, L | 1 |
| Shapira, R | 1 |
| Daudi, N | 1 |
| Klein, A | 1 |
| Shouval, D | 1 |
| Mor, E | 1 |
| Tur-Kaspa, R | 1 |
| Dinari, G | 1 |
| Ben-Ari, Z | 1 |
| Nguyen, MH | 1 |
| Henkes, M | 1 |
| Martin, S | 1 |
| Einsele, H | 1 |
| Aulitzky, WE | 1 |
16 reviews available for brl 42810 and Hepatitis B Virus Infection
| Article | Year |
|---|---|
Famciclovir: a focus on efficacy and safety.
Topics: 2-Aminopurine; Antiviral Agents; Famciclovir; Female; Hepatitis B; Hepatitis B virus; Herpesviridae | 2010 |
Antiviral agents: Non-antiretroviral [correction of Nonantiviral] drugs.
Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Chickenpox; Cytomegalovirus Infections; Famciclovir; Fos | 2002 |
Hepatitis B: progress in the last 15 years.
Topics: 2-Aminopurine; Antiviral Agents; Famciclovir; Hepatitis B; Humans; Immunoglobulins; Liver Transplant | 2002 |
Treatment of recurrence of hepatitis B in transplant patients.
Topics: 2-Aminopurine; Antiviral Agents; Drug Resistance, Microbial; Famciclovir; Hepatitis B; Humans; Immun | 2003 |
New nucleoside analogues for chronic hepatitis B.
Topics: 2-Aminopurine; Antiviral Agents; Arabinofuranosyluracil; Chronic Disease; Drug Evaluation, Preclinic | 1995 |
New developments in antiviral therapy for chronic hepatitis B infection.
Topics: 2-Aminopurine; Antiviral Agents; Arabinofuranosyluracil; Clinical Trials as Topic; Famciclovir; Hepa | 1995 |
Famciclovir: review of clinical efficacy and safety.
Topics: 2-Aminopurine; Animals; Antiviral Agents; Drug Resistance, Microbial; Famciclovir; Hepatitis B; Herp | 1996 |
Treatment of posttransplantation hepatitis B.
Topics: 2-Aminopurine; Antiviral Agents; Famciclovir; Ganciclovir; Hepatitis B; Humans; Lamivudine; Liver Tr | 1997 |
Clinical experience with famciclovir against hepatitis B virus.
Topics: 2-Aminopurine; Administration, Oral; Amino Acid Sequence; Antiviral Agents; Drug Resistance, Microbi | 1997 |
[New management of hepatitis B virus].
Topics: 2-Aminopurine; Adrenal Cortex Hormones; Antiviral Agents; Famciclovir; Germanium; Hepatitis B; Human | 1999 |
Hepatitis B virus infection and bone marrow transplantation.
Topics: 2-Aminopurine; Antiviral Agents; Biomarkers; Bone Marrow Transplantation; Famciclovir; Hepatitis B; | 1999 |
Preclinical aspects of lamivudine and famciclovir against hepatitis B virus.
Topics: 2-Aminopurine; Antiviral Agents; Famciclovir; Hepatitis B; Hepatitis B virus; Humans; Lamivudine | 1999 |
Posttransplantation: emerging and future therapies.
Topics: 2-Aminopurine; Antiviral Agents; Drug Therapy, Combination; Famciclovir; Ganciclovir; Hepatitis B; H | 2000 |
Antiviral therapy to prevent and treat hepatitis B virus infection in hepatic allografts.
Topics: 2-Aminopurine; Antiviral Agents; Drug Combinations; Drug Resistance, Microbial; Famciclovir; Gancicl | 2000 |
Resistance of hepatitis B virus to antiviral drugs: current aspects and directions for future investigation.
Topics: 2-Aminopurine; Adenine; Amino Acid Sequence; Animals; Anti-HIV Agents; Antimetabolites; Antiviral Ag | 2001 |
Therapeutic advances in the management of hepatitis B and hepatitis C.
Topics: 2-Aminopurine; Antiviral Agents; Drug Therapy, Combination; Famciclovir; Hepatitis B; Hepatitis C; H | 2001 |
6 trials available for brl 42810 and Hepatitis B Virus Infection
| Article | Year |
|---|---|
Lamivudine and famciclovir combination therapy with or without addition of interferon-alpha-2b for HBeAg-positive chronic hepatitis B: a pilot study.
Topics: 2-Aminopurine; Adult; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Famciclovir; Female; | 2002 |
A prospective study on chemotherapy-induced hepatitis B virus reactivation in chronic HBs Ag carriers with hematologic malignancies and pre-emptive therapy with nucleoside analogues.
Topics: 2-Aminopurine; Adult; Aged; Antineoplastic Agents; Antiviral Agents; Chronic Disease; Famciclovir; F | 2006 |
A double blind, placebo-controlled study to assess the effect of famciclovir on virus replication in patients with chronic hepatitis B virus infection.
Topics: 2-Aminopurine; Adolescent; Adult; Antiviral Agents; Carrier State; Chronic Disease; DNA, Viral; Doub | 1996 |
Long-term results of famciclovir for recurrent or de novo hepatitis B virus infection after liver transplantation.
Topics: 2-Aminopurine; Adult; Antiviral Agents; Famciclovir; Female; Hepatitis B; Humans; Liver Transplantat | 1999 |
Lamivudine as first- and second-line treatment of hepatitis B infection after liver transplantation.
Topics: 2-Aminopurine; Anti-HIV Agents; Antiviral Agents; Famciclovir; Hepatitis B; Hepatitis B virus; HIV; | 2000 |
[Prevention and treatment of HBV reinfection following liver transplantation].
Topics: 2-Aminopurine; Adult; Antiviral Agents; Biopsy; DNA, Viral; Drug Combinations; Famciclovir; Female; | 2002 |
39 other studies available for brl 42810 and Hepatitis B Virus Infection
| Article | Year |
|---|---|
A decline in hepatitis B virus surface antigen (hbsag) predicts clearance, but does not correlate with quantitative hbeag or HBV DNA levels.
Topics: 2-Aminopurine; Antiviral Agents; DNA, Viral; Famciclovir; Female; Heart Transplantation; Hepatitis B | 2008 |
The use of antiviral monotherapy and combination therapy for patients with hepatitis B virus infection after liver transplantation.
Topics: 2-Aminopurine; Antiviral Agents; Drug Therapy, Combination; Famciclovir; Hepatitis B; Hepatitis B Su | 2002 |
Treatment of recurrent hepatitis B infection in liver transplant recipients.
Topics: 2-Aminopurine; Adenine; Antiviral Agents; Famciclovir; Hepatitis B; Humans; Interferon-alpha; Lamivu | 2002 |
Prophylaxis and treatment of hepatitis B virus reinfection following liver transplantation.
Topics: 2-Aminopurine; Adult; Antiviral Agents; DNA, Viral; Dose-Response Relationship, Drug; Drug Therapy, | 2002 |
Drugs for non-HIV viral infections.
Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Cytomegalovirus Infections; Drug Resistance, Viral; Famc | 2005 |
Lamivudine and famciclovir treatment in HIV patients with acute hepatitis B virus infection and hepatitis B reactivation.
Topics: 2-Aminopurine; Alanine Transaminase; Antiviral Agents; Aspartate Aminotransferases; Famciclovir; Hep | 2007 |
Acute necrotico-hemorrhagic pancreatitis after famciclovir prescription.
Topics: 2-Aminopurine; Acute Disease; Alanine Transaminase; Amylases; Antiviral Agents; Bilirubin; Cyclospor | 1995 |
Prostaglandin E plus famciclovir--a new concept for the treatment of severe hepatitis B after liver transplantation.
Topics: 2-Aminopurine; Antiviral Agents; Carcinoma, Hepatocellular; DNA, Viral; Famciclovir; Follow-Up Studi | 1994 |
Famciclovir therapy for recurrent hepatitis B virus infection after liver transplantation.
Topics: 2-Aminopurine; Antiviral Agents; DNA, Viral; Famciclovir; Hepatitis B; Humans; Liver Transplantation | 1996 |
Treatment of hepatitis B-related polyarteritis nodosa with famciclovir and interferon alfa-2b.
Topics: 2-Aminopurine; Antiviral Agents; DNA, Viral; Famciclovir; Hepatitis B; Hepatitis B Antibodies; Hepat | 1997 |
Pretransplant famciclovir as prophylaxis for hepatitis B virus recurrence after liver transplantation.
Topics: 2-Aminopurine; Adult; Antiviral Agents; DNA, Viral; Famciclovir; Hepatitis Antibodies; Hepatitis B; | 1997 |
[Famciclovir plus interferon in the treatment of a patient with chronic hepatitis B and severe liver failure].
Topics: 2-Aminopurine; Antiviral Agents; Drug Therapy, Combination; Famciclovir; Hepatitis B; Hepatitis, Chr | 1997 |
Hepatitis B virus infection and liver transplantation.
Topics: 2-Aminopurine; Antiviral Agents; Famciclovir; Hepatitis B; Hepatitis B Vaccines; Humans; Immunizatio | 1997 |
Conversion of recurrent delta-positive hepatitis B infection to seronegativity with famciclovir after liver transplantation.
Topics: 2-Aminopurine; Antigens, Viral; Antiviral Agents; Famciclovir; Hepatitis B; Hepatitis B virus; Hepat | 1997 |
Use of famciclovir to prevent HBV reactivation in HBsAg-positive recipients after allogeneic bone marrow transplantation.
Topics: 2-Aminopurine; Adolescent; Adult; Antiviral Agents; Bone Marrow Transplantation; Famciclovir; Female | 1998 |
Postliver transplant allograft reinfection with a lamivudine-resistant strain of hepatitis B virus: long-term follow-up.
Topics: 2-Aminopurine; Adult; Antiviral Agents; Drug Resistance, Microbial; Famciclovir; Female; Follow-Up S | 1998 |
[Prevention of hepatitis B--analysis of cost-effectiveness after liver transplantation].
Topics: 2-Aminopurine; Adult; Antiviral Agents; Cost-Benefit Analysis; Famciclovir; Female; Hepatitis B; Hum | 1997 |
Advances in the treatment of viral hepatitis.
Topics: 2-Aminopurine; Antiviral Agents; Famciclovir; Hepatitis B; Hepatitis C; Hepatitis, Viral, Human; Hum | 1998 |
Resolution of recurrent hepatitis B in two liver transplant recipients treated with famciclovir.
Topics: 2-Aminopurine; Antiviral Agents; Famciclovir; Female; Hepatitis B; Humans; Liver Transplantation; Mi | 1998 |
The sequential occurrence of viral mutations in a liver transplant recipient re-infected with hepatitis B: hepatitis B immune globulin escape, famciclovir non-response, followed by lamivudine resistance resulting in graft loss.
Topics: 2-Aminopurine; Amino Acid Sequence; Antiviral Agents; DNA-Directed DNA Polymerase; DNA, Viral; Drug | 1998 |
Absence of mutations in the YMDD motif/B region of the hepatitis B virus polymerase in famciclovir therapy failure.
Topics: 2-Aminopurine; Amino Acid Sequence; Amino Acid Substitution; Antiviral Agents; DNA Replication; Famc | 1999 |
Mutational pattern of hepatitis B virus on sequential therapy with famciclovir and lamivudine in patients with hepatitis B virus reinfection occurring under HBIg immunoglobulin after liver transplantation.
Topics: 2-Aminopurine; Adult; Amino Acid Substitution; Antiviral Agents; DNA Primers; DNA-Directed DNA Polym | 1999 |
Is nucleoside analogue monotherapy sufficient for treatment of HBV infection? Lessons from HIV.
Topics: 2-Aminopurine; Anti-HIV Agents; Antiviral Agents; Deoxyguanosine; Famciclovir; Hepatitis B; HIV Infe | 1999 |
Selection of multiresistant hepatitis B virus during sequential nucleoside-analogue therapy.
Topics: 2-Aminopurine; Antiviral Agents; DNA-Directed DNA Polymerase; DNA, Viral; Drug Resistance, Microbial | 2000 |
Lamivudine improves the prognosis of patients with hepatitis B after liver transplantation.
Topics: 2-Aminopurine; Antiviral Agents; Famciclovir; Follow-Up Studies; Hepatitis B; Humans; Lamivudine; Li | 2000 |
Fatal hepatic decompensation in a patient with hepatitis B cirrhosis following famciclovir withdrawal.
Topics: 2-Aminopurine; Adult; Antiviral Agents; Famciclovir; Fatal Outcome; Hepatitis B; Humans; Liver Cirrh | 2000 |
Comparison of famciclovir and lamivudine in the long-term treatment of hepatitis B infection after liver transplantation.
Topics: 2-Aminopurine; Adult; Aged; Antiviral Agents; DNA, Viral; Famciclovir; Female; Hepatitis B; Hepatiti | 2001 |
Famciclovir treatment in transplant recipients with HBV-related liver disease: disappointing results.
Topics: 2-Aminopurine; Adult; Alanine Transaminase; Antiviral Agents; DNA, Viral; Famciclovir; Female; Follo | 2001 |
[Current treatment of hepatitis B].
Topics: 2-Aminopurine; Adenine; Anti-Inflammatory Agents; Antiviral Agents; DNA Replication; Famciclovir; Fo | 2001 |
[Laboratory diagnosis of hepatitis B].
Topics: 2-Aminopurine; Acute Disease; Antiviral Agents; DNA Replication; DNA, Viral; Drug Resistance; Famcic | 2001 |
Severe clinical course of de novo hepatitis B infection after liver transplantation.
Topics: 2-Aminopurine; Adult; Antiviral Agents; Famciclovir; Fatal Outcome; Female; Hepatitis B; Humans; Lam | 2001 |
Famciclovir treatment of hepatitis B infection following liver transplantation: a long-term, multi-centre study.
Topics: 2-Aminopurine; Adolescent; Adult; Aged; Alanine Transaminase; Antiviral Agents; Child; DNA, Viral; F | 2001 |
Analysis of hepatitis B viral load decline under potent therapy: complex decay profiles observed.
Topics: 2-Aminopurine; Antiviral Agents; Computer Systems; DNA, Viral; Drug Therapy, Combination; Famciclovi | 2001 |
Preoperative antiviral treatment and postoperative prophylaxis in HBV-DNA positive patients undergoing liver transplantation.
Topics: 2-Aminopurine; Adult; Antiviral Agents; DNA, Viral; Famciclovir; Female; Hepatitis B; Humans; Immuno | 2001 |
Failure of combination therapy with lamivudine and famciclovir following lamivudine monotherapy for hepatitis B virus infection in patients coinfected with human immunodeficiency virus-1.
Topics: 2-Aminopurine; Antiviral Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Famciclovir; | 2001 |
Efficacy of famciclovir in the treatment of lamivudine resistance related to an atypical hepatitis B virus mutant.
Topics: 2-Aminopurine; Adult; DNA, Viral; Drug Resistance, Microbial; Famciclovir; Female; Hepatitis B; Hepa | 2002 |
[B domain mutations in the polymerase gene of hepatitis B virus during combination therapy with thymosin alpha1 and famciclovir in Chinese asymptomatic HBV carriers].
Topics: 2-Aminopurine; Adjuvants, Immunologic; Antiviral Agents; Binding Sites; DNA Mutational Analysis; DNA | 2000 |
Seroconversion after the addition of famciclovir therapy in a child with hepatitis B virus infection after liver transplantation who developed lamivudine resistance.
Topics: 2-Aminopurine; Alanine Transaminase; Antiviral Agents; Child, Preschool; DNA, Viral; Drug Resistance | 2002 |
Successful antiviral treatment for fulminant reactivated hepatitis B after autologous stem cell transplantation and prophylaxis during subsequent allogeneic stem cell transplantation.
Topics: 2-Aminopurine; Adult; Antiviral Agents; Famciclovir; Female; Hematopoietic Stem Cell Transplantation | 2002 |